Klenzaids Pharmaceutics Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2007.
2007 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Klenzaids Pharmaceutics Private Limited

Klenzaids Pharmaceutics Private Limited, a struck off private limited company, was established on 21 June 2007 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24230MH2007PTC171877. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M.

Its leadership includes Chandru Mangaram Shahani (Director), Mehernosh Eruch Engineer (Director), Monisha Amit Narke (Director). It is based at A-21 Midc Industrial Area, Street No.3 Opp. Esic Hospital, Midc, Andheri (East), Mumbai, Maharashtra, 400093.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2007PTC171877

  • Registration Number

    171877

  • Incorporation Date

    21 June 2007

  • Authorized Capital

    ₹0.50 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Company Age 18 Year, 8 Months
Company report

Klenzaids Pharmaceutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Klenzaids Pharmaceutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Klenzaids Pharmaceutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Chandru Mangaram Shahani Director 21 Jun 2007 Current
Mehernosh Eruch Engineer Director 21 Jun 2007 Current
Monisha Amit Narke Director 21 Jun 2007 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Klenzaids Pharmaceutics.

Enhance accessibility to Klenzaids Pharmaceutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Klenzaids Pharmaceutics revenue growth over time
Klenzaids Pharmaceutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Klenzaids Pharmaceutics?

Unlock access to Klenzaids Pharmaceutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Klenzaids Pharmaceutics?

Unlock and access historical data on people associated with Klenzaids Pharmaceutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Klenzaids Pharmaceutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Klenzaids Pharmaceutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Klenzaids Pharmaceutics
Recent Activity within the Organization
  • Director Appointment

    The activity Chandru Mangaram Shahani was appointed as a Director was appointed as a Director on 21 Jun 2007 & has been associated with this company since 18 years 8 months . was completed.

  • Director Appointment

    Progress on Mehernosh Eruch Engineer was appointed as a Director was appointed as a Director on 21 Jun 2007 & has been associated with this company since 18 years 8 months . was documented.

  • Director Appointment

    Monisha Amit Narke was appointed as a Director was appointed as a Director on 21 Jun 2007 & has been associated with this company since 18 years 8 months . was recorded as a recent event.

  • Company Incorporation

    Klenzaids Pharmaceutics Private Limited was registered on 21 Jun 2007 with Roc Mumbai & aged 18 years 8 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Klenzaids Pharmaceutics Private Limited?

The CIN of Klenzaids Pharmaceutics Private Limited is U24230MH2007PTC171877.

Where is Klenzaids Pharmaceutics Private Limited headquartered?

Klenzaids Pharmaceutics Private Limited is headquartered at A-21 Midc Industrial Area, Street No.3 Opp. Esic Hospital, Midc, Andheri (East), Mumbai, Maharashtra, 400093.

When was Klenzaids Pharmaceutics Private Limited incorporated?

Klenzaids Pharmaceutics Private Limited was incorporated on 21 June 2007.

Who are the current directors of Klenzaids Pharmaceutics Private Limited?

The current directors of Klenzaids Pharmaceutics Private Limited are

What is the primary industry of Klenzaids Pharmaceutics Private Limited?

The primary industry of Klenzaids Pharmaceutics Private Limited is Chemicals.

Is Klenzaids Pharmaceutics Private Limited a listed company?

Klenzaids Pharmaceutics Private Limited is unlisted.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available